Experience in Phase I Trials and an Upcoming Phase II Study with uPA Inhibitors in Metastatic Breast Cancer.
Goldstein
Lori J
LJ
Fox Chase Cancer Center, Philadelphia, USA.
Cancer Res. 1994 May 15;54(10):2527-30
8168072
Clin Cancer Res. 2001 Sep;7(9):2757-64
11555589
Cancer. 1996 Aug 1;78(3):487-92
8697395
Cell Mol Life Sci. 2000 Jan 20;57(1):25-40
10949579
Nat Med. 1996 Jul;2(7):725
8673908
N Engl J Med. 2007 Dec 27;357(26):2666-76
18160686
Cancer Res. 1988 Mar 1;48(5):1348-9
3124957
J Clin Oncol. 1995 Aug;13(8):2084-93
7636552
J Clin Oncol. 2002 Feb 15;20(4):1000-7
11844823
Ann N Y Acad Sci. 1995 Jan 17;748:367-81; discussion 381-2
7695179
J Natl Cancer Inst. 2002 Jan 16;94(2):116-28
11792750
J Natl Cancer Inst. 2001 Jun 20;93(12):913-20
11416112
Br J Cancer. 1997;75(3):388-95
9020484
N Engl J Med. 2001 Mar 15;344(11):783-92
11248153
J Clin Oncol. 2002 Jun 15;20(12):2812-23
12065558
J Natl Cancer Inst. 1996 Oct 16;88(20):1456-66
8841020
J Clin Oncol. 2003 Mar 15;21(6):1022-8
12637466
Breast Cancer Res Treat. 1999 Mar;54(2):147-57
10424405
Cancer Res. 1994 Jun 1;54(11):2900-7
8187075
Lancet. 1989 Oct 28;2(8670):1049
2572788
Int J Cancer. 1998 Oct 23;79(5):449-54
9761111
J Urol. 1996 Mar;155(3):858-62
8583593
Clin Cancer Res. 2001 Aug;7(8):2448-57
11489825
Clin Cancer Res. 2000 Mar;6(3):1052-62
10741734
Expert Opin Biol Ther. 2001 Jul;1(4):683-91
11727504
J Clin Oncol. 2007 Nov 20;25(33):5287-312
17954709